These beneficial properties of RSV can, at least in part, be blocked by co-administration of ZnPP, which is a HO-1 inhibitor, suggesting a definite crosstalk between renal HO-1 enzyme and these pathways contributing to the initiation and progress of DN. This evidence concerns the gene HMOX1 and liver dysplastic nodule.